![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Clements C John McIntyre Peter B
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.5, Iss.1, 2006-01, pp. : 17-29
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The benefit-risk balance of thiomersal-containing vaccines remains overwhelmingly positive
Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMEA supports safety of thiomersal-containing vaccines
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cardiovascular Risk-Benefit Profile of Sibutramine
By Scheen A.J.
American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)